Evidence map›Paper›PMID 35135375›Full record

ArticleDiabetes & vascular disease research

Aspirin use in patients with diagnosed diabetes in the United States and China: Nationally representative analysis.

Xin Wang, Guang Hao, Zuo Chen, Linfeng Zhang, Yuting Kang, Ying Yang, Congyi Zheng, Haoqi Zhou, Lu Chen, Zengwu Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Diabetes & vascular disease research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xin WangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Guang HaoDepartment of Epidemiology, 569172School of Medicine, Jinan University, Guangzhou, China.ORCID 0000-0003-3780-0223
Zuo ChenDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Linfeng ZhangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Yuting KangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Ying YangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Congyi ZhengDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Haoqi ZhouDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Lu ChenDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Zengwu WangDivision of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, 47885Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.ORCID 0000-0003-1613-5076
Runlin GaoDepartment of Cardiology, Fuwai Hospital, 34736Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe epidemiological data on the use of aspirin in diabetic patients is very limited. The main purpose of this study is to examine the current status of aspirin use in the United States (US) and China in large representative populations.

methodsData came from the National Health and Nutrition Examination Survey (NHANES) and China Hypertension Survey (CHS), two nationally representative cross-sectional studies.

resultsThe percentage of aspirin use was 73.8% in US diabetic patients with ASCVD, and the percentage of aspirin use in diabetic patients with high ASCVD risk was marginally higher in men (

conclusionsIn summary, the percentage of aspirin use in primary prevention in US diabetic patients in men was higher than in women, and this percentage for primary and secondary prevention in US patients was higher than that in Chinese patients.

Indexed as

Cardiovascular DiseasesDiabetes MellitusAspirinChinaCross-Sectional StudiesFemaleHumansMaleNutrition SurveysRisk FactorsUnited StatesAspirinAspirin useChinadiabetesUnited States

Identifiers

PMID35135375
PMCPMC8867494
OpenAlexW4210984938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.